This inventor holds 3 USPTO granted patents. Top assignees: Quell Therapeutics Limited, Fundação Universidade Federal Do Abc - Ufabc, Technische Universitat Braunschweig. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
1 out of 1 
1 out of 38 Years Active: 2025-2026
Title: Michael Hust: Innovator in Biotechnology
Introduction
Michael Hust is a prominent inventor based in Braunschweig, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 3 patents, Hust's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents, Hust has developed recombinant human antibodies that inhibit the human tissue kallikrein 7 (KLK7) and their use against diseases that cause desquamation of the skin. Additionally, he has worked on a CAR for use in the treatment of HVG disease. These innovations highlight his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Michael Hust has collaborated with notable organizations, including Quell Therapeutics Limited and Fundação Universidade Federal Do Abc - Ufabc. His work in these companies has allowed him to further his research and contribute to groundbreaking developments in biotechnology.
Collaborations
Hust has worked alongside esteemed colleagues such as Elmar Jäckel and Fatih Noyan. These collaborations have enriched his research and fostered a collaborative environment for innovation.
Conclusion
Michael Hust's contributions to biotechnology through his patents and collaborations demonstrate his dedication to advancing medical treatments. His work continues to inspire future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile